Devil's Claw Extract

Botanicaljoint supportModerate dose evidence

Also known as: Harpagophytum procumbens, harpagoside, grapple plant, wood spider

Add to a formula

Devil's claw is a southern African plant whose secondary root tubers contain harpagoside and related iridoid glycosides. It is used in European phytotherapy for joint comfort and low-back discomfort. A systematic review of 12 trials found moderate to strong evidence for aqueous extracts delivering 50–100 mg harpagoside daily and weaker evidence for lower-harpagoside ethanolic extracts. Extracts are typically standardized to 5% or more harpagoside and dosed by harpagoside content.

Research summary

Harpagoside and related iridoids inhibit COX-2 and inflammatory cytokine expression in vitro.

Dosage

Daily amounts, of extract.

Lowest studiedTypical rangeHighest studiedUpper limit
600–1,200 mg

Dose by harpagoside: 50–100 mg per day, which is 600–1,200 mg of an 8.3% extract or 1,000–2,000 mg of a 5% extract. Take with food. Effects were assessed over 4–12 weeks in trials.

Standardization: ≥5% harpagoside (higher-strength extracts 8–9%)

Source material: secondary root tuber extract

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Very bitter; capsules and tablets standard. Traditional liquid extracts exist. Gram-level doses raise capsule counts.

Formulation notes

May increase stomach acid; traditionally cautioned with peptic ulcers and gallstones. Possible additive effect with anticoagulants and blood-pressure medications.

Sources

  1. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. (Gagnier, 2004)PubMed

Related ingredients